Fingerprint
Dive into the research topics of 'High-dose cytarabine as salvage therapy for relapsed or refractory acute myeloid leukemia-is more better or more of the same?'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
High-dose cytarabine as salvage therapy for relapsed or refractory acute myeloid leukemia-is more better or more of the same?
Ofir Wolach, Gilad Itchaki, Michal Bar-Natan, Moshe Yeshurun, Ron Ram, Corina Herscovici, Ofer Shpilberg, Dan Douer, Martin S. Tallman, Pia Raanani
Research output: Contribution to journal › Article › peer-review
11
Scopus
citations